HC Wainwright Reaffirms “Buy” Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $9.00 price target on the stock. Several other equities analysts also recently commented on LCTX. D. Boral Capital restated a “buy” rating […]
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $9.00 price target on the stock. Several other equities analysts also recently commented on LCTX. D. Boral Capital restated a “buy” rating […]
